Sano Genetics Secures $11.4M for Precision Medicine Research
Sano Genetics, a software company that is revolutionizing precision medicine research, has secured $11.4M in new funding.
Stay updated with breaking news from Sano Genetics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Sano Genetics, a software company that is revolutionizing precision medicine research, has secured $11.4M in new funding.
Sano Genetics, a software company accelerating precision medicine research, has raised $11.4 million in new funding, led by Plural with participation from existing investors including MMC Ventures, Episode 1 and Seedcamp. Founded by Patrick Short (CEO), Charlotte Guzzo (COO) and William Jones (CTO), Sano Genetics ...
Sano Genetics says it is developing software that will enable ‘the precision medicine revolution’ and has raised $11.4 million in new funding.
Sano Genetics is at the forefront of the personalised medicine trend:Its platform accelerates the process for bringing new drugs to market, by bringing the right patients onto the trial and leveraging AI to manage all aspects of clinical trialsIt connects patients across four countries including the US, UK, Canada a...
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!